The project, which aims to develop unique treatment approaches and new generation drug-active molecules against castration-resistant metastatic prostate cancer, led by Prof. Tuğba Tümer, was deemed worthy of support with a budget of 800,000 TL within the scope of TUSEB Research and Development Projects Support Program.